1. CMU Intellectual Repository

Browsing by Author Unchalee Permsuwan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 44  next >
Issue DateTitleAuthor(s)
1-Jan-2022The affordability of adding a direct-acting oral anticoagulant to the national list of essential medicine for patients with non-valvular atrial fibrillation in Thailand: a budget impact analysisPiyameth Dilokthornsakul; Unchalee Permsuwan
1-Feb-2012Anticoagulation control of pharmacist-managed collaborative care versus usual care in ThailandSurasak Saokaew; Ubonwan Sapoo; Surakit Nathisuwan; Nathorn Chaiyakunapruk; Unchalee Permsuwan
1-Feb-2018Biphasic insulin aspart 30 treatment for people with type 2 diabetes: a budget impact analysis based in ThailandChaicharn Deerochanawong; Natapong Kosachunhanun; Pitthaporn Chotikanokrat; Unchalee Permsuwan
24-Dec-2014Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) databaseWimon Suwankesawong; Surasak Saokaew; Unchalee Permsuwan; Nathorn Chaiyakunapruk
1-Jan-2010Confirmatory factor analysis of an instrument to assess quality in pharmacy service of highly-active antiretroviral therapy programWacharin Chaitha; Chupen Viboonsunti; Unchalee Permsuwan; Ratanaporn Awipan; Penkarn Karnjanarat
1-Jul-2006Cost-benefit analysis of an intensive adverse product reactions monitoring program of inpatients in ThailandJanejira Tasila; Unchalee Permsuwan
1-Dec-2011Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancerSumitra Thongprasert; Unchalee Permsuwan; Chidchanok Ruengorn; Chaiyut Charoentum; Busyamas Chewaskulyong
1-Sep-2015Cost-Effectiveness Analysis of Fondaparinux vs Enoxaparin in Non-ST Elevation Acute Coronary Syndrome in ThailandUnchalee Permsuwan; Nathorn Chaiyakunapruk; Surakit Nathisuwan; Apichard Sukonthasarn
1-Jan-2019Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial FibrillationPiyameth Dilokthornsakul; Surakit Nathisuwan; Rungroj Krittayaphong; Aurauma Chutinet; Unchalee Permsuwan
21-Jun-2018Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in ThailandRungroj Krittayaphong; Unchalee Permsuwan
1-Jan-2019Cost-effectiveness analysis of the adjunctive therapy of ivabradine for the treatment of heart failure with reduced ejection fractionRungroj Krittayaphong; Jirawit Yadee; Unchalee Permsuwan
1-Jan-2020Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure in ThailandUnchalee Permsuwan; Arintaya Phrommintikul; Voratima Silavanich
21-Sep-2016Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in ThailandUnchalee Permsuwan; Piyameth Dilokthornsaku; Surasak Saokaew; Kednapa Thavorn; Nathorn Chaiyakunapruk
1-Feb-2017Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in ThailandUnchalee Permsuwan; Piyameth Dilokthornsakul; Kednapa Thavorn; Surasak Saokaew; Nathorn Chaiyakunapruk
2-Sep-2017Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspectiveUnchalee Permsuwan; Kednapa Thavorn; Piyameth Dilokthornsakul; Surasak Saokaew; Nathorn Chaiyakunapruk
1-Oct-2013Cost-effectiveness of pharmacist-participated warfarin therapy management in ThailandSurasak Saokaew; Unchalee Permsuwan; Nathorn Chaiyakunapruk; Surakit Nathisuwan; Apichard Sukonthasarn; Napawan Jeanpeerapong
1-Jan-2020Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fractionRungroj Krittayaphong; Unchalee Permsuwan
1-Sep-2022Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection FractionRungroj Krittayaphong; Unchalee Permsuwan
1-May-2020Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in ThailandUnchalee Permsuwan; Sumitra Thongprasert; Buntitabhon Sirichanchuen
1-Oct-2021Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in ThailandRungroj Krittayaphong; Unchalee Permsuwan
Showing results 1 to 20 of 44  next >